Sort by:
Keyphrases
Aptamer
82%
SELEX
45%
C Domain
25%
N-domain
25%
Immunosuppressive Microenvironment
25%
Bone Loss
25%
Hydroxysteroid Dehydrogenase
25%
Dickkopf-1 (DKK1)
25%
High-fat Diet
25%
Diet-induced
25%
Linker
25%
Osteoblastic
25%
Obesity
25%
High Affinity
25%
Hybrid Deep Learning
25%
Tumor-infiltrating
25%
Programmed Death-ligand 1 (PD-L1)
25%
Small Interfering RNA (siRNA)
25%
Targeted Tumor
25%
Regulatory T Cells
25%
Chimera
25%
Cluster of Differentiation 47 (CD47)
25%
Male Mice
10%
Osteoblast
10%
Metabolic Disorders
10%
In Vitro Techniques
9%
Myeloid-derived Suppressor Cells
8%
Glucose Handling
7%
Glucocorticoid Signaling
7%
Tumor Growth
6%
Living Organisms
6%
Physiological Relevance
6%
Regulatory T
6%
Solid Tumors
6%
Glycolysis
6%
LRP6
5%
Composition Feature
5%
Affinity Sequence
5%
Aptamer Technology
5%
Iterative Selection
5%
Weak Binding
5%
Binding Affinity
5%
Bidirectional Long Short-term Memory (BiLSTM)
5%
Structural Features
5%
Model Combining
5%
Hybrid Neural Network
5%
High Failure Rate
5%
Binding Potential
5%
Convolutional Neural Network
5%
Sequence Composition
5%
Experimental Bias
5%
Non-specific Interaction
5%
Target Binding
5%
Tight-binding
5%
Nucleic Acid Aptamer
5%
Binding Motif
5%
Biochemistry, Genetics and Molecular Biology
Aptamer
100%
PD-L1
25%
Small Interfering RNA
25%
CD47
25%
Myeloid
22%
DKK1
20%
Systematic Evolution of Ligands by Exponential Enrichment
20%
Tumor Progression
20%
Regulatory T Cell
20%
LRP6
15%
Catenin
12%
T Cell
10%
CD8
7%
Immune Response
5%
Short Term Memory
5%
Binding Affinity
5%
Oligonucleotide
5%
Immune Checkpoint Inhibitor
5%
Cell Infiltration
5%
Angiogenesis
5%
Immune Checkpoints
5%
Cancer Immunotherapy
5%
Aerobic Metabolism
5%
Gene Inactivation
5%
Immune Evasion
5%
Beta Oxidation
5%
Reprogramming
5%
Immunology and Microbiology
In Vitro
30%
Immunosuppressive Drug
25%
Programmed Death-Ligand 1
25%
CD47
25%
Myeloid-Derived Suppressor Cell
25%
Regulatory T Cell
20%
Catenin
13%
Immunotherapy
8%
Pharmacokinetic
8%
Cytotoxic T-Cell
7%
Immune Checkpoint Inhibitor
5%
Immune Response
5%
Angiogenesis
5%
Fatty Acid Oxidation
5%
Gene Inactivation
5%
Cell Infiltration
5%
Immune Evasion
5%
Aerobic Metabolism
5%
Cancer Immunotherapy
5%